Uveeka Therapeutics Private Limited
About Uveeka Therapeutics Private Limited
Data last updated:
Uveeka Therapeutics Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the service-based operations segment of the business services sector. It was incorporated on 28 April 2017.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC294440.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Hitashi Juss and Satwant Singh Juss.
Its last annual general meeting (AGM) was held on 29 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at 16/702 Shanti Garden Chs Ltd Sector No 6 Behind Royal College Shantidham, Mumbai, Maharashtra, India – 401107.
Company details
Contact details
Uveeka Therapeutics Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address16/702 Shanti Garden Chs Ltd Sector No 6 Behind Royal College Shantidham, Mumbai, Maharashtra, India – 401107
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Uveeka Therapeutics Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Uveeka Therapeutics Private Limited, buy the company report.
Board of directors of Uveeka Therapeutics Private Limited
Uveeka Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hitashi Juss | Director | 28 Apr 2017 | 9 Years 6 Months | As last reported |
| Satwant Singh Juss | Director | 28 Apr 2017 | 9 Years 6 Months | As last reported |
Legal cases
No court or tribunal cases involving Uveeka Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uveeka Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Uveeka Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Uveeka Therapeutics Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Hitashi Juss was appointed as Director on 28 Apr 2017.
Frequently asked questions
Uveeka Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Uveeka Therapeutics was a private limited company based in Mumbai, Maharashtra, India. The company worked in other services, within the business services industry. It was incorporated on 28 April 2017 and is registered under CIN U74999MH2017PTC294440. The company has been struck off by the Registrar of Companies and is no longer operational.
Uveeka Therapeutics had 2 directors:
- Hitashi Juss - Director
- Satwant Singh Juss - Director
The CIN (Corporate Identification Number) of Uveeka Therapeutics is U74999MH2017PTC294440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Uveeka Therapeutics is at 16702 Shanti Garden Chs Ltd Sector No 6 Behind Royal College Shantidham, Mumbai, Maharashtra, India – 401107.
Uveeka Therapeutics was incorporated on 28 April 2017. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Uveeka Therapeutics on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 29 September 2019. Year-wise statements from FY 2018 are in the company report.
Uveeka Therapeutics operated in the business services industry, in the other services segment. It worked in this industry before it was struck off.
Hitashi Juss was appointed as Director on 28 Apr 2017. Satwant Singh Juss was appointed as Director on 28 Apr 2017.
The compliance status of Uveeka Therapeutics is compliant as of 02 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
